412 related articles for article (PubMed ID: 32929325)
1. Lack of FGF21 promotes NASH-HCC transition
Zheng Q; Martin RC; Shi X; Pandit H; Yu Y; Liu X; Guo W; Tan M; Bai O; Meng X; Li Y
Theranostics; 2020; 10(22):9923-9936. PubMed ID: 32929325
[No Abstract] [Full Text] [Related]
2. Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice.
Yu Y; Shi X; Zheng Q; Wang X; Liu X; Tan M; Lv G; Zhang P; Martin RC; Li Y
Int J Biol Sci; 2021; 17(10):2576-2589. PubMed ID: 34326695
[No Abstract] [Full Text] [Related]
3. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
4. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
5. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.
Miura K; Ishioka M; Minami S; Horie Y; Ohshima S; Goto T; Ohnishi H
J Biol Chem; 2016 May; 291(22):11504-17. PubMed ID: 27022031
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet.
Singhal G; Kumar G; Chan S; Fisher FM; Ma Y; Vardeh HG; Nasser IA; Flier JS; Maratos-Flier E
Mol Metab; 2018 Jul; 13():56-66. PubMed ID: 29753678
[TBL] [Abstract][Full Text] [Related]
7. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC.
Grohmann M; Wiede F; Dodd GT; Gurzov EN; Ooi GJ; Butt T; Rasmiena AA; Kaur S; Gulati T; Goh PK; Treloar AE; Archer S; Brown WA; Muller M; Watt MJ; Ohara O; McLean CA; Tiganis T
Cell; 2018 Nov; 175(5):1289-1306.e20. PubMed ID: 30454647
[TBL] [Abstract][Full Text] [Related]
8. Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice.
Liu X; Zhang P; Martin RC; Cui G; Wang G; Tan Y; Cai L; Lv G; Li Y
Am J Cancer Res; 2016; 6(5):1011-25. PubMed ID: 27293995
[TBL] [Abstract][Full Text] [Related]
9. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.
Conde de la Rosa L; Garcia-Ruiz C; Vallejo C; Baulies A; Nuñez S; Monte MJ; Marin JJG; Baila-Rueda L; Cenarro A; Civeira F; Fuster J; Garcia-Valdecasas JC; Ferrer J; Karin M; Ribas V; Fernandez-Checa JC
J Hepatol; 2021 Jun; 74(6):1429-1441. PubMed ID: 33515644
[TBL] [Abstract][Full Text] [Related]
10. Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling.
Benbow JH; Thompson KJ; Cope HL; Brandon-Warner E; Culberson CR; Bossi KL; Li T; Russo MW; Gersin KS; McKillop IH; deLemos AS; Schrum LW
Am J Pathol; 2016 Jan; 186(1):145-58. PubMed ID: 26603137
[TBL] [Abstract][Full Text] [Related]
11. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
12. TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis.
Wang X; Zeldin S; Shi H; Zhu C; Saito Y; Corey KE; Osganian SA; Remotti HE; Verna EC; Pajvani UB; Schwabe RF; Tabas I
J Hepatol; 2022 Apr; 76(4):910-920. PubMed ID: 34902531
[TBL] [Abstract][Full Text] [Related]
13. Hepatic TLR4 signaling in obese NAFLD.
Sharifnia T; Antoun J; Verriere TG; Suarez G; Wattacheril J; Wilson KT; Peek RM; Abumrad NN; Flynn CR
Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(4):G270-8. PubMed ID: 26113297
[TBL] [Abstract][Full Text] [Related]
14. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis.
Jin K; Shi Y; Zhang H; Zhangyuan G; Wang F; Li S; Chen C; Zhang J; Wang H; Zhang W; Sun B
J Hepatol; 2023 Aug; 79(2):403-416. PubMed ID: 37040844
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
[TBL] [Abstract][Full Text] [Related]
16. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
Tucker RD; Ciofoaia V; Nadella S; Gay MD; Cao H; Huber M; Safronenka A; Shivapurkar N; Kallakury B; Kruger AJ; Kroemer AHK; Smith JP
Dig Dis Sci; 2020 Jan; 65(1):189-203. PubMed ID: 31297627
[TBL] [Abstract][Full Text] [Related]
17. IL-17A-mediated ERK1/2/p65 signaling pathway is associated with cell apoptosis after non-alcoholic steatohepatitis.
Pan YJ; Ren X; Zhang YY; Lv J; Zeng QL; Zhang HY; Yu ZJ
IUBMB Life; 2019 Mar; 71(3):302-309. PubMed ID: 30481403
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
20. Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in Mice.
Roh YS; Kim JW; Park S; Shon C; Kim S; Eo SK; Kwon JK; Lim CW; Kim B
Am J Pathol; 2018 Nov; 188(11):2574-2588. PubMed ID: 30125542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]